Recent applications of next-generation sequencing (NGS) technologies have led to great progress in disease diagnosis, prognosis and treatment. As genome sequencing increases and more associations are being made between genetic variants and an increased risk of developing a disease or the response to a drug therapy, scientific knowledge increases and so does identification of biomarkers of genetic predisposition to diseases, biomarkers for diagnosis of any genetic disease, biomarkers which allow prediction of response to a medical treatment, etc.



Precision medicine is a new way of practising medicine, which will provide a new paradigm for health care in general by allowing physicians to offer a true response to each individual´s unique health demands based on a finer-grained understanding of disease biology and the implementation of tailored health interventions.